Estamos realizando la búsqueda. Por favor, espere...
1452
37
174
32671
4708
2710
372
420
Abstract: Human glial cell line-derived neurotrophic factor (hGDNF) is a very promising protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The present work describes a quick and simple method to obtain a high amount of purified hGDNF using a mammalian cell-derived system. The method is based on the high expression level provided by a Semliki Forest virus vector and its ability to induce a strong shut-off of host-cell protein synthesis in mammalian cells. As a result, hGDNF is the only protein present in the supernatant and can be efficiently purified by a single chromatographic step. Using this system it was possible to eliminate other secreted proteins from the culture medium, like insulin-like growth factor-5, which are hard to remove using other hGDNF production methods. Purified hGDNF presents a complex glycosylation pattern typical of mammalian expression systems and is biologically active. This protocol could be extended to other secreted proteins and could be easily scaled up for industrial purposes.
Fuente: International Journal of Pharmaceutics, 2013, 440(1), 19-26
Editorial: Elsevier
Año de publicación: 2013
Nº de páginas: 8
Tipo de publicación: Artículo de Revista
DOI: 10.1016/j.ijpharm.2012.04.071
ISSN: 0378-5173,1873-3476
Url de la publicación: https://doi.org/10.1016/j.ijpharm.2012.04.071
SCOPUS
Citas
Google Scholar
Métricas
Leer publicación
ANSORENA, EDUARDO
CASALES, ERKUDEN
ARANDA, ALEJANDRO
ESTHER TAMAYO REVUELTA
GARBAYO, ELISA
SMERDOU, CRISTIAN
BLANCO-PRIETO, MARIA J.
AYMERICH, MARIA S.
Volver